Literature DB >> 16026410

Follicle-stimulating hormone receptor polymorphisms in a population of infertile women.

Henrik Falconer1, Eva Andersson, Arthur Aanesen, Gabriel Fried.   

Abstract

BACKGROUND: There are two known polymorphisms of clinical relevance in the follicle-stimulating hormone (FSH) receptor exon 10, alanine or threonine at position 307, and asparagine or serine at position 680, giving rise to two discrete allelic variants: Thr307/Asn680 and Ala307/Ser680. At position 680, three FSH receptor variants are possible: Asn/Asn, Asn/Ser, and Ser/Ser. We hypothesized an association between FSH receptor polymorphisms and ovarian reserve.
METHODS: FSH receptor polymorphisms at position 680 were studied in a population of 68 infertile women. We used serum FSH level at cycle day 3 as a screening for ovarian reserve. DNA was extracted from peripheral leukocytes in whole blood by using PCR and DNA sequencing in order to determine the type of FSH receptor.
RESULTS: The distribution of FSH receptor variants was Asn/Asn (AA) 35%, Asn/Ser (AS) 24%, and Ser/Ser (SS) 41%. In women with normal ovarian reserve, FSH levels at cycle day 3 were 5.6 +/- 1.9 (AA group), 6.7 +/- 1.3 (AS group), and 5.7 +/- 1.7 (SS group) (non-significant). Corresponding FSH levels at cycle day 10 were 6.9 +/- 1.9, 6.3 +/- 1.7, and 8.3 +/- 2.8 (P < 0.01, AA and AS vs. SS group). In the SS group, FSH levels at cycle day 10 were significantly higher than they were at cycle day 3 (P < 0.05).
CONCLUSIONS: The results show that Ser/Ser-680 predominates in the studied infertile population. Furthermore, women with normal ovarian reserve and the Ser/Ser FSH receptor variant had significantly higher FSH levels, compared to women with Asn/Asn and Asn/Ser variants. FSH receptor genotyping may, thus, be interesting as an adjunct indicator of ovarian reserve for infertile women undergoing assisted reproduction, and may be helpful in the determination of the starting dosage of FSH in in vitro fertilization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026410     DOI: 10.1111/j.0001-6349.2005.00736.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  9 in total

1.  The carriers of the A/G-G/G allelic combination of the c.2039 A>G and c.-29 G>A FSH receptor polymorphisms retrieve the highest number of oocytes in IVF/ICSI cycles.

Authors:  Adolfo Allegra; Angelo Marino; Stefania Raimondo; Antonio Maiorana; Salvatore Gullo; Piero Scaglione; Aldo Volpes; Riccardo Alessandro
Journal:  J Assist Reprod Genet       Date:  2016-11-05       Impact factor: 3.412

2.  Enhanced hypothalamic-pituitary sensitivity to estrogen in premenopausal women with diminished ovarian reserve compared with older perimenopausal controls.

Authors:  Katie Zhang; Gohar Zeitlian; Goli Adel; Nanette F Santoro; Lubna Pal
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

3.  Impact of follicle-stimulating hormone receptor variants in female infertility.

Authors:  Nermin Seda Ilgaz; Oya Sena Erdogan Aydos; Aynur Karadag; Mehmet Taspinar; Ozlem Gun Eryilmaz; Asuman Sunguroglu
Journal:  J Assist Reprod Genet       Date:  2015-09-24       Impact factor: 3.412

Review 4.  Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols.

Authors:  Carlo Alviggi; Peter Humaidan; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-02-06       Impact factor: 5.211

5.  Relationship Between Genotype Variants Follicle-stimulating Hormone Receptor Gene Polymorphisms (FSHR) and Morphology of Oocytes Prior to ICSI Procedures.

Authors:  Zafer Gashi; Shkelzen Elezaj; Afrim Zeqiraj; Driton Grabanica; Isak Shabani; Bujar Gruda; Fitore Gashi
Journal:  Med Arch       Date:  2016-10-25

6.  The impact of FSH receptor polymorphism on time-to-pregnancy: a cross-sectional single-centre study.

Authors:  Birute Zilaitiene; Marius Dirzauskas; Rasa Verkauskiene; Rytas Ostrauskas; Joerg Gromoll; Eberhard Nieschlag
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-28       Impact factor: 3.007

7.  Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus.

Authors:  Alessandro Conforti; Frank Tüttelmann; Carlo Alviggi; Hermann M Behre; Robert Fischer; Liang Hu; Nikolaos P Polyzos; Dana Chuderland; Gottumukkala Achyuta Rama Raju; Thomas D'Hooghe; Manuela Simoni; Sesh K Sunkara; Salvatore Longobardi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

Review 8.  Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response.

Authors:  M Simoni; C B Tempfer; B Destenaves; B C J M Fauser
Journal:  Hum Reprod Update       Date:  2008-07-04       Impact factor: 15.610

9.  RANKL is a new Epigenetic Biomarker for the Vasomotor Symptom During Menopause.

Authors:  R Kalkan; M Altarda; O Tosun
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.